Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03830112
Other study ID # Mat Pilates
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date August 14, 2018
Est. completion date March 30, 2019

Study information

Verified date June 2019
Source Universidad de Antioquia
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Based on the current evidence, it is known that Pilates is an exercise technique that has been used mainly by women in sport, fitness and rehabilitation. Most research has been developed with women. The participation of men in the research studies is reduced and methodology rigor is low, therefore, there is insufficient evidence on the effects of this type of training in men, in addition, there are no studies that have proven the effects of a Pilates-based mat exercise with resistance band on strength of core muscles.

The main objective of this research is to identify the effects of a Pilates-based mat exercise program versus a Pilates-based exercise mat program with resistance band on the isometric strength of the core muscles in men 18 to 25 years.


Description:

Fifty-eight men will be randomly assigned to one of two Pilates exercise programs. Pilates-based mat exercise and Pilates-based mat exercise with TherabandĀ® (blue color). Interventions will be performed three times a week for eight-weeks on alternate days. Half will perform Pilates-based mat exercise and the remaining 29 will perform Pilates-based mat exercise with TherabandĀ®. Both groups complete eleven exercises from week one to four and twelve exercises from week five to eight.


Recruitment information / eligibility

Status Completed
Enrollment 58
Est. completion date March 30, 2019
Est. primary completion date February 20, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 18 Years to 25 Years
Eligibility Inclusion Criteria:

- Healthy volunteers.

- Perform =150 minutes of aerobic exercise per week.

Exclusion Criteria:

- Perform any Pilates exercise previously.

- Smoker.

- History of asthma.

- History of diabetes.

- History of hypertension.

- History of cardiovascular disease.

- History of coronary heart disease.

- Arrhythmias.

- Under medical treatment with anticoagulants, beta-blockers, calcium antagonists, bronchodilators, and/or steroids.

- Psychological, neuromotor and/or osteo-muscular conditions that may affect participation in an exercise program.

- People with metal prosthesis.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Pilates exercise with Theraband
The experimental group will perform all the exercises with Theraband® in the same manner than active comparator group.
Pilates exercise
The active comparator group will perform all the exercises without Theraband®

Locations

Country Name City State
Colombia Centro de Formación en Actividad Física y Cultura Bogotá Cundinamarca

Sponsors (1)

Lead Sponsor Collaborator
Universidad de Antioquia

Country where clinical trial is conducted

Colombia, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in isometric strength of the core muscles Isometric strength of the core muscles will be obtained using TorsoCheck (Ergo-FitĀ®, Germany). Baseline and after 8 weeks
Secondary Change in lean mass Lean mass will be obtained using Bioelectrical impedance (SECA mBCA515, Gmbh&Co.,Hamburg,Germany) Baseline and after 8 weeks
Secondary Change in body fat Body fat will be obtained using Bioelectrical impedance (SECA mBCA515,Gmbh&Co.,Hamburg,Germany). Baseline and after 8 weeks
See also
  Status Clinical Trial Phase
Completed NCT05001152 - Taste Assessment of Ozanimod Phase 1
Completed NCT05029518 - 3-Way Crossover Study to Compare the PK (Pharmokinetics) and to Evaluate the Effect of Food on the Bioavailability Phase 1
Completed NCT04493255 - A Study to Determine the Metabolism and Elimination of [14C]E7090 in Healthy Male Participants Phase 1
Completed NCT03457649 - IV Dose Study to Assess the Safety, Tolerability, PK, PD and Immunogenicity of ARGX-113 in Healthy Volunteers Phase 1
Completed NCT00995891 - Collection of Blood, Bone Marrow, and Buccal Mucosa Samples From Healthy Volunteers for Center for Human Immunology, Autoimmunity, and Inflammatory Diseases (CHI) Laboratory Research Studies
Completed NCT05043766 - Evaluation of Oral PF614 Relative to OxyContin Phase 1
Completed NCT05050318 - Annual Study for Collection of Serum Samples in Children and Older Adults Receiving the 2021-2022 Formulations of Fluzone Quadrivalent Vaccine and Fluzone High-Dose Quadrivalent Vaccine, Respectively Phase 4
Completed NCT04466748 - A Multiple Ascending Dose Pharmacology Study of Anaprazole in Healthy Chinese Subjects Phase 1
Completed NCT00746733 - Vyvanse and Adderall XR Given Alone and in Combination With Prilosec OTC Phase 1
Recruiting NCT05929651 - Study of Immunogenicity and Safety of MenQuadfi® as a Booster Vaccine in Toddlers 12 to 23 Months, Regardless of the Quadrivalent Meningococcal Conjugate Vaccine Used for Priming in Infancy Phase 4
Completed NCT05954039 - Evaluation of the Efficacy of a Dietary Supplement on Hair Loss and Hair Aspect N/A
Completed NCT05045716 - A Study of Subcutaneous Lecanemab in Healthy Participants Phase 1
Active, not recruiting NCT02747927 - Efficacy, Safety and Immunogenicity of Takeda's Tetravalent Dengue Vaccine (TDV) in Healthy Children Phase 3
Completed NCT05533801 - A Study to Demonstrate the Bioequivalence of Lecanemab Supplied in Vials and a Single-Use Auto-Injector (AI) in Healthy Participants Phase 1
Not yet recruiting NCT03931369 - Adaptation of Thirst to a Single Administration of Tolvaptan (TOLVATHIRST) Phase 2
Completed NCT03279146 - A Single Dose Study Evaluating PK of TXL Oral Formulations in Healthy Subjects Phase 1
Completed NCT06027437 - A Study to Assess the Relative Biological Availability and the Effect of Food on the Drug Levels of Danicamtiv in Healthy Adult Participants Phase 1
Recruiting NCT05619874 - Effects of Two Virtual HIFCT Programs in Adults With Abdominal Obesity N/A
Completed NCT05553418 - Investigational On-body Injector Clinical Study N/A
Completed NCT04092712 - Study Evaluating Pharmacokinetics and Mass Balance of [14C]-CTP-543 in Healthy Adult Male Volunteers Phase 1